A small molecule antagonist of SMN disrupts the interaction between SMN and RNAP II

Abstract excerpt

Survival of motor neuron (SMN) functions in diverse biological pathways via recognition of symmetric dimethylarginine (Rme2s) on proteins by its Tudor domain, and deficiency of SMN leads to spinal muscular atrophy. Here we report a potent and selective antagonist with a 4-iminopyridine scaffold targeting the Tudor domain of SMN. Our structural and mutagenesis studies indicate that both the aromatic ring and imino...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to RNA modifications and cancer
• Share to Neurogenetic and Muscular Disorders Research
• Share to Signaling Pathways in Disease